Cutler Group’s Aethlon Medical AEMD Stock Holding History

Cutler Group’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Hold	0	–	–	–	2198
2023 Q4	–	Hold	0	–	–	–	3547
2023 Q3	–	Hold	0	–	–	–	3725
2023 Q2	–	Hold	0	–	–	–	3498
2023 Q1	–	Hold	0	–	–	–	3691
2022 Q4	–	Sell	-1	Closed	-$1.82K	–	4294
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	4396
2022 Q2	$2K	Hold	1	–	–	﹤0.01%	4200
2022 Q1	$3K	Hold	1	–	–	﹤0.01%	4388
2021 Q4	$4K	Hold	1	–	–	﹤0.01%	4282
2021 Q3	$15K	Buy	+1	New	+$16.8K	﹤0.01%	3572
2021 Q2	–	Hold	0	–	–	–	5592

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Cutler Group's AEMD Position: Q1 2024 in Review

Cutler Group held its Aethlon Medical (AEMD) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Cutler Group first reported a position in AEMD in Q3 2021 and has held it in 5 quarters since. The position peaked at $15K in Q3 2021. 7 funds tracked by Wall St. Rank hold AEMD as of Q1 2024.

Cutler Group held 0 shares of Aethlon Medical worth $0 as of Q1 2024.
Cutler Group left its Aethlon Medical share count unchanged in Q1 2024.
Aethlon Medical made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #2198 holding.
Cutler Group first reported a position in Aethlon Medical in Q3 2021 and has held it in 5 quarters since.
Cutler Group's Aethlon Medical position peaked at $15K in Q3 2021.
7 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.